Del Sette Capital Management, LLC Crispr Therapeutics Ag Transaction History
Del Sette Capital Management, LLC
- $116 Million
- Q2 2024
A detailed history of Del Sette Capital Management, LLC transactions in Crispr Therapeutics Ag stock. As of the latest transaction made, Del Sette Capital Management, LLC holds 36,841 shares of CRSP stock, worth $1.8 Million. This represents 1.71% of its overall portfolio holdings.
Number of Shares
36,841Holding current value
$1.8 Million% of portfolio
1.71%Shares
4 transactions
Others Institutions Holding CRSP
# of Institutions
523Shares Held
58MCall Options Held
1.73MPut Options Held
1.84M-
Capital International Investors Los Angeles, CA7.87MShares$385 Million0.09% of portfolio
-
Cathie Wood Ark Investment Management LLC | St. Petersburg, Fl7.78MShares$381 Million3.82% of portfolio
-
Nikko Asset Management Americas, Inc.3.15MShares$154 Million1.99% of portfolio
-
Sumitomo Mitsui Trust Holdings, Inc.3.15MShares$154 Million0.13% of portfolio
-
Black Rock Inc. New York, NY2.78MShares$136 Million0.0% of portfolio
About CRISPR Therapeutics AG
- Ticker CRSP
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 78,009,296
- Market Cap $3.82B
- Description
- CRISPR Therapeutics AG, a gene editing company, focuses on developing gene-based medicines for serious diseases using its proprietary Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR)/CRISPR-associated protein 9 (Cas9) platform. Its CRISPR/Cas9 is a gene editing technology that allows for precise directed changes to genomic DNA....